DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings You may also like Navigating Behaviors: Strategies for Support & Success – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Nurturing Mental Wellness in Everyday Life – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Updates in Research & Care for Carriers – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Therapies That Slow Progression – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings A New Take on the Ins and Outs – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings How MRI is Advancing Drug Development for Duchenne – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Finding Light in the Journey: Fostering Resilience, Gratitude & Hope – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings Cardiac Management Throughout the Lifespan – 2025 PPMD Annual Conference 1 year ago 2025 PPMD Annual Conference,Conferences & Meetings «123456…29»Page 4 of 29